Aimei Health Technology Co., Ltd. (AFJK): Nasdaq/NYSE listing notice — Aimei Health receives Nasdaq delisting notice for delayed Q1 10-Q

Aimei Health Technology Co., Ltd.

Notice received on May 19, 2026 for failure to file Q1 10-Q due May 15, 2026.
Company has 60 calendar days to file or submit a compliance plan to Nasdaq.
If plan accepted, up to 180 days from due date to regain compliance; otherwise possible delisting.
No immediate effect on trading; company says working diligently to file.
Press release issued May 20, 2026 per Nasdaq Rule 5810(b).

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Aimei Health Technology Co., Ltd. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

May 19, 2026, Aimei Health Technology Co., Ltd (the “ Company ”) received a notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Co

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Aimei Health Technology Co., Ltd. filing history →

Source: SEC EDGAR

accession 0001493152-26-024600

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.